Lipson Cancer Institute - Linden Oaks

Clinical research site in Rochester, New York · RRH Lipson Cancer Institute, 20 Hagen Dr #100, Rochester, NY 14625 · (585) 922-4020 · Website

As of July 2026, 1 paid clinical trial is recruiting at Lipson Cancer Institute - Linden Oaks in Rochester, New York. Active studies at this site focus on Triple Negative Breast Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Lipson Cancer Institute - Linden Oaks (1)

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

124 locations incl. Birmingham

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

Explore more

Paid clinical trials in Rochester, NY · New York clinical trials

Lipson Cancer Institute - Linden Oaks

Recruiting clinical trials at Lipson Cancer Institute - Linden Oaks (1)

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

More research sites in Rochester

Explore more